![Elisa Scarselli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Elisa Scarselli first degree
Entity | Entity type | Industry | |
---|---|---|---|
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
16
| Holding Company | Pharmaceuticals: Major | 16 |
Nouscom Srl
10
| Subsidiary | Miscellaneous Commercial Services | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Elisa Scarselli via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Okairos AG
![]() Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder Founder Founder Corporate Officer/Principal Director/Board Member | |
The American University of Rome | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Reithera Srl
![]() Reithera Srl Real Estate Investment TrustsFinance ReiThera Srl is a contract development and manufacturing organization (CDMO) based in Rome, Italy. The Italian company specializes in technology and process development, as well as GMP manufacturing, to support the clinical translation of genetic vaccines and medicinal products for advanced therapies. ReiThera has extensive expertise in developing scalable processes for viral-vector manufacturing and has a consolidated experience in GMP production of various types of viral vectors. The company's state-of-the-art facility includes bioreactors of different scales, a filling suite, and quality control laboratories. ReiThera's international team has contributed to several research projects aimed at unlocking the potential of innovative prophylactic and therapeutic programs. ReiThera Srl is dedicated to meeting the highest demand for the development, manufacture, and storage of viral vectors, drugs, and clinical samples. The company was founded in 2005 by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, and Stefano Colloca, who is also the CEO. | Real Estate Investment Trusts | Founder Founder Chief Executive Officer Chief Executive Officer | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
NANEXA AB | Medical Specialties | Chairman Director/Board Member | |
CELYAD ONCOLOGY SA | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Università degli Studi di Napoli Federico II | College/University | Undergraduate Degree Doctorate Degree | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Université Catholique de Louvain | College/University | Doctorate Degree Graduate Degree | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
Versant EuroVentures | Chief Executive Officer | ||
Anabasis SRL
![]() Anabasis SRL Miscellaneous Commercial ServicesCommercial Services Part of Dompé SpA, Anabasis SRL provides biopharmaceutical research and development services. The company is based in Milan, Italy. The Italian company was founded by Francesco Sinigaglia. Anabasis was acquired by Dompé SpA on February 27, 2012. | Miscellaneous Commercial Services | Director/Board Member | |
PIQUR Therapeutics AG
![]() PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
Vaximm AG
![]() Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
AM-Pharma Holding BV
![]() AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Mosaic Biomedicals SL
![]() Mosaic Biomedicals SL Hospital/Nursing ManagementHealth Services Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain. | Hospital/Nursing Management | Director/Board Member | |
AM-Pharma BV
![]() AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Iowa State University | College/University | Undergraduate Degree | |
Cooperative Elevator Co.
![]() Cooperative Elevator Co. Agricultural Commodities/MillingProcess Industries Cooperative Elevator Co. engages in the trading and supply of beans and grains to food processors. Its products include corn, dry beans, soybeans, wheat, and organic beans. The company was founded on November 26, 1915 and is headquartered in Pigeon, MI. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
Rc Manufacturing LLC | Corporate Officer/Principal | ||
Versant Ventures (Switzerland) GmbH | Investment Managers | Private Equity Investor | |
Biotie Therapies AG
![]() Biotie Therapies AG Pharmaceuticals: MajorHealth Technology Part of Acorda Therapeutics, Inc., Biotie Therapies AG is a holding company that focuses on developing drugs for the treatment of psychiatry and neurology diseases. The company is based in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer | |
BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Director/Board Member | |
Abingworth Management Ltd.
![]() Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Abingworth LLP
![]() Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Investor | |
Credit Suisse Securities (Europe) Ltd.
![]() Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Analyst-Equity | |
Ipsen Bioinnovation Ltd.
![]() Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Abingworth Avillion Blocker Ltd. | Director/Board Member | ||
Aravis AG
![]() Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Investment Managers | Private Equity Investor | |
MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MOLMED S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
Advent SRL | Chief Executive Officer | ||
JV Bio SRL | Corporate Officer/Principal | ||
Novartis Vaccines & Diagnostics, Inc.
![]() Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Adolor Corp.
![]() Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Director/Board Member |
Statistics
International
United States | 16 |
Switzerland | 11 |
Italy | 8 |
United Kingdom | 7 |
Sweden | 4 |
Sectoral
Health Technology | 29 |
Consumer Services | 7 |
Finance | 7 |
Commercial Services | 3 |
Health Services | 2 |
Operational
Director/Board Member | 131 |
Corporate Officer/Principal | 35 |
Chairman | 30 |
Independent Dir/Board Member | 28 |
Doctorate Degree | 18 |
Most connected contacts
Insiders | |
---|---|
Göran Albert Ando | 44 |
Scott Rocklage | 32 |
Jean-Paul Prieels | 32 |
Guido Magni | 23 |
Joachim Rothe | 22 |
Genghis Lloyd-Harris | 19 |
Vincent Brichard | 15 |
John McDonald | 11 |
Riccardo Cortese | 9 |
Adrian Woolfson | 6 |
Richard Davis | 6 |
Marina Udier | 6 |
Richard Davis | 5 |
Alfredo Nicosia | 5 |
Cinzia Traboni | 4 |
- Stock Market
- Insiders
- Elisa Scarselli
- Company connections